Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:41 AM
Ignite Modification Date:
2025-12-25 @ 2:41 AM
NCT ID:
NCT00915733
Eligibility Criteria:
Inclusion Criteria:
1. The patient must be at least 18 years of age.
2. clinical symptoms compatible with acute myocardial ischemia within 12 h before admission with a subsequently documented increase in cardiac markers.
3. Measured pre-discharge platelet reactivity in case of normalized CK-MB value after coronary stenting.
Exclusion Criteria:
1. A history of active bleeding and bleeding diatheses.
2. Oral anticoagulation therapy with coumadin.
3. Contraindication to antiplatelet therapy.
4. LV ejection fraction \< 30% or NYHA 3/4.
5. Leukocyte count \< 3,000/mm3 and/or platelet count \< 100,000/mm3.
6. AST or ALT ≥ 3 times upper normal.
7. Serum creatinine level ≥ 2.5 mg/dl.
8. Stroke within 3 months.
9. Non-cardiac disease with a life expectancy \< 1 year.
10. Inability to follow the protocol.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00915733
Study Brief:
Protocol Section:
NCT00915733